Molecular and Imaging Studies of Cardiovascular Health and Disease
Launched by NATIONAL HEART CENTRE SINGAPORE · Jun 14, 2016
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the "Molecular and Imaging Studies of Cardiovascular Health and Disease," is focused on understanding heart health and various heart conditions, including dilated cardiomyopathy, hypertrophic cardiomyopathy, and ischemic heart disease. Researchers are collecting biological samples, health information, and imaging data from participants to study how these factors relate to heart health over time. This program is important as it aims to develop better ways to diagnose and treat heart diseases.
If you are between the ages of 16 and 90 and are interested in participating, you are eligible to join, as there are no other specific requirements. Participants will provide samples and health information to help with this research. There’s no treatment or medication involved in this study; it’s primarily about gathering information to help advance our understanding of heart health. This could lead to better care for patients with heart conditions in the future. If you're curious about heart health and want to contribute to important research, this trial could be a great opportunity!
Gender
ALL
Eligibility criteria
- • There is no inclusion/exclusion criteria except for the age limit as this is a repository program.
- Inclusion Criteria:
- • •Subject aged ≥ 16 years and ≤ 90 years.
- Exclusion Criteria:
- • •No
About National Heart Centre Singapore
The National Heart Centre Singapore (NHCS) is a leading institution dedicated to advancing cardiovascular care and research in Singapore and the Asia-Pacific region. As a premier clinical trial sponsor, NHCS is committed to improving heart health through innovative research and clinical excellence. The center specializes in a wide range of cardiovascular conditions, leveraging cutting-edge technology and a multidisciplinary approach to develop and evaluate new therapies. With a strong emphasis on patient-centered care, NHCS collaborates with various stakeholders to enhance clinical outcomes and contribute to the global body of cardiovascular knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Singapore, , Singapore
Patients applied
Trial Officials
Stuart Cook, MBBS,PhD
Principal Investigator
National Heart Centre Singapore
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials